Understanding drug toxicity through gene expression

We worked with Syngenta – a leading agricultural and biotechnology company – to design bioinformatics tools for high throughput screening of candidate compounds.

Credit: Dreamstime


Assessing the toxic potential of a molecule is an essential element in drug discovery. Toxicity, an undesirable effect caused by a drug at a certain dose and time, can be defined by a set of observable characteristics – phenotypes – caused by changes in underlying gene expression patterns. Assessing toxicity requires a deep understanding of the underlying gene expression. Toxicogenomics – an interdisciplinary, data-driven field uses various technologies to measure gene signatures. An emerging, cheap, rapid, high-throughput technology – L1000 – has the potential to become the standard method of generating gene expression profiles for toxicogenomic studies, allowing mass screening of molecules at a lower cost. Syngenta were interested in evaluating the potential of the L1000 platform to identify related data-driven methods that could influence future work in investigative and predictive toxicity.


Researchers first developed a bioinformatics pipeline to automate the processing of, L1000 data sets and went on to perform pathway enrichment, translating high dimensional gene expression profiles to relevant physiological processes to drug toxicity. This was followed by using high-dimensional network biology techniques, enabling the translation of genotypes to phenotypes. Data from the L1000 platform was coupled with machine learning pipelines to generate in silico predictive models that could classify potential toxicity using gene expression profiles from cell lines treated for a range of candidate compounds.​


Completed as part of the Innovation Return on Research (IROR) programme, a collaboration between STFC and IBM Research – the tools and techniques developed provided Syngenta with a fresh perspective regarding the adoption of data-driven, machine learning-based techniques for further exploitation of L1000 datasets in their research programme, helping establish building blocks that can be continuously refined as Syngenta expands their library of L1000 datasets in future.​

“These tools provide the basis of the future development of our approach to interpret highthroughput transcriptomics data, helping us accelerate innovation of new technologies that help farmers to sustainably produce the food, feed, fuel, fibre, and related inputs society needs​. Our predictive toxicology exploratory programme looks at the use of highthroughput transcriptomics to help predict the toxicity of new crop protection chemicals. There were no off-the-shelf solutions to analyse the high throughput data and provide insights we require. Researchers at STFC Hartree Centre demonstrated the ability of computational bioinformatic and machine learning approaches to combine transcriptomics, high dimensional network biology and chemical structure data to predict toxicity.”

Richard Currie, Syngenta

Join Newsletter

Provide your details to receive regular updates from the STFC Hartree Centre.